Haworth RA, Potter KT, Russell DC. Role of arachidonic acid, lipoxygenase, and mitochondrial depolarization in reperfusion arrhythmias. Am J Physiol Heart Circ Physiol 299: H165-H174, 2010. First published April 30, 2010 doi:10.1152/ajpheart.00906.2009.-We have sought evidence that arachidonic acid (AA) induces mitochondrial depolarization in isolated myocytes by a lipoxygenase (LOX)-dependent mechanism and that such depolarization might contribute to arrhythmogenesis following ischemia-reperfusion injury. A method was developed for measuring mitochondrial depolarization in isolated adult rat myocytes in suspension, using tetramethylrhodamine ethyl ester. The addition of AA to myocytes resulted in mitochondrial depolarization that was inhibited by the LOX inhibitor baicalein, by the reactive oxygen species (ROS) scavenger mercaptoproprionylglycine, and by the anion channel inhibitor diisothiocyanatostilbenedisulfonic acid (DIDS). AA induced mitochondrial uncoupling and mitochondrial ATPase activity in myocytes, but both were insensitive to baicalein. We conclude that the metabolic effect of AA in myocytes puts mitochondria into an energetically compromised state where membrane potential is easily changed by the DIDS-sensitive LOX/ ROS-mediated opening of an inner membrane anion channel. In an in vivo anesthetized rat model of coronary artery occlusion, baicalein was found to strongly inhibit arrhythmias induced by ischemiareperfusion injury. Arrhythmias following ischemia-reperfusion injury have been previously associated with DIDS-sensitive ROSmediated mitochondrial depolarization, and free fatty acids including AA were previously found to accumulate during such injury. We therefore conclude that arrhythmias following ischemia-reperfusion injury might originate from mitochondrial depolarization mediated by LOX and AA. mitochondria; ischemia; reperfusion; reactive oxygen species; anion channels RECENTLY, EVIDENCE HAS EMERGED that a direct link may exist between mitochondrial depolarization and arrhythmias induced by ischemia-reperfusion injury via the activation of an inner membrane anion channel (IMAC) and the coincident oscillatory activation of the sarcolemmal ATP-sensitive K ϩ channel (sK ATP ), resulting in action potential duration shortening (1, 2). However, the mechanism by which ischemia-reperfusion injury induces the reactive oxygen species (ROS)-dependent IMAC activity and mitochondrial depolarization remains unclear.
RECENTLY, EVIDENCE HAS EMERGED that a direct link may exist between mitochondrial depolarization and arrhythmias induced by ischemia-reperfusion injury via the activation of an inner membrane anion channel (IMAC) and the coincident oscillatory activation of the sarcolemmal ATP-sensitive K ϩ channel (sK ATP ), resulting in action potential duration shortening (1, 2) . However, the mechanism by which ischemia-reperfusion injury induces the reactive oxygen species (ROS)-dependent IMAC activity and mitochondrial depolarization remains unclear.
A long-standing hypothesis of arrhythmogenesis is that an excess of plasma free fatty acids induced by ischemia-reperfusion injury impairs glucose metabolism and damages membranes (43) . This hypothesis is supported by several observations: patients with acute myocardial ischemia who had particularly high plasma concentrations of free fatty acids also had an increased incidence of ventricular arrhythmias and ventricular fibrillation (VF) (44, 51) ; ischemia-reperfusion injury causes a rise in the level of free fatty acids, including arachidonic acid (AA), which in rat hearts increases 13-fold (up to 63 nmol/g) with 1 h ischemia and 30 min reperfusion (15) ; and arrhythmias can be induced by perfusion of hearts with high levels of free fatty acids (40) . Recent support for this hypothesis is evidence that Ca 2ϩ -insensitive phospholipase A 2 activity is required for arrhythmogenesis associated with ischemiareperfusion injury, highlighting the potential role of phospholipid hydrolysis (41) . The fatty acid hypothesis however, has languished for lack of a specific mechanism by which free fatty acids might be shown to act to induce arrhythmias (43) .
We present evidence here that AA via lipoxygenase (LOX) activity induces mitochondrial depolarization in isolated myocytes and also that it contributes to arrhythmogenesis following ischemia-reperfusion injury. This mechanism, therefore, may be the link between free fatty acids and arrhythmogenesis.
MATERIALS AND METHODS
The investigation conforms with the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996), using protocols approved by our Institutional Animal Care and Use Committee.
Sources of chemicals. Chemicals were obtained from Sigma Chemical, except for baicalein, which was obtained from Calbiochem (cell studies) and from Cayman Chemical (in vivo rat studies).
Myocyte isolation. Myocytes were isolated from adult female Sprague-Dawley rats as previously described (24) and were resuspended in a Krebs-Henseleit-HEPES experimental medium containing (in mM) 118 NaCl, 4.8 KCl, 25 HEPES, 1.2 MgSO 4, 1.2 KH2PO4, 1.0 CaCl 2, and 11 glucose, adjusted to pH 7.4 with NaOH. In some experiments (where indicated), glucose was omitted from the medium.
Membrane potential measurements with tetramethylrhodamine ethyl ester. Myocyte suspensions were loaded with 100 nM tetramethylrhodamine ethyl ester (TMRE) by incubation for 15 min at room temperature. They were then centrifuged and resuspended in experimental medium at 0.8 mg/ml before division into separate flasks for each experimental condition, which were performed concurrently. Cell suspensions were brought to at 37°C 15 min before time 0. Additions were made to flasks as described in the figures, and 0.5-ml aliquots were centrifuged at the times shown. TMRE fluorescence in the supernatant was measured on a plate reader.
ATP measurements. ATP content of cell suspensions was measured using a luciferase assay (Perkin Elmer ATPlite).
Lactate measurements. Lactate concentrations were measured on neutralized perchloric acid extracts of cell suspension aliquots as described previously (23) .
Oxygen consumption. Rates of oxygen consumption were measured on cells suspended in experimental medium at 0.8 mg/ml using a Clark oxygen electrode as described previously (26) . Cells were not stimulated to beat.
In vivo model of ischemia-reperfusion injury. We used a rat model of coronary artery ligation adapted from Guo et al. (20) . Briefly, male Sprague-Dawley rats weighing between 250 and 300 g were used in the experiments. All animals were handled according to the guidelines approved by the Animal Care and Use Committee of the University of Wisconsin and of the Wm S. Middleton Memorial Veterans Hospital. Rats were anesthetized with isoflurane (2-3%). A tracheotomy was performed and an intubation cannula was connected to a rodent ventilator. The right jugular vein and carotid artery were cannulated for the administration of drugs and the measurements of mean arterial pressure and heart rate, respectively. A two-lead electrocardiogram was recorded with the PowerLab BioAmp. Mean arterial pressure, heart rate, and electrocardiogram were continuously recorded on the PowerLab data acquisition system. Body temperature was monitored via a rectal thermometer and maintained at or near 37°C. A left thoracotomy was performed at the fifth intercostal space. The pericardium was incised and retracted to expose the heart. A polypropylene suture (No. 6/0) was placed around the left anterior descending coronary artery (LAD), close to its origin, with suture threads exteriorized. The suture ends were threaded through an occluder made from a 1-cm section of rigid polyethylene tubing (outer diameter, 2.5 mm). Regional myocardial ischemia was induced by tightening the occluder, and reperfusion was achieved by releasing the occluder. Successful coronary artery occlusion was confirmed by regional cyanosis of the heart. Successful reperfusion was indicated by recovery from cyanosis.
After initial surgical procedures, 30 min were allowed for stabilization before LAD occlusion. All rats were subjected to 5 min of LAD occlusion followed by 30 min of reperfusion. All vehicle and drugs were administered intravenously as a bolus injection within 30 s. The rats were divided into two groups of six rats each: 1) control group (1 l/g saline) and 2) baicalein group (1 l/g of 20 mg/ml baicalein).
Assessment of arrhythmias. Arrhythmias were assessed according to the criteria of the Lambeth conventions (52) . Ventricular tachycardia (VT) was defined as a run of four or more consecutive ventricular premature ventricular complexes. VF was defined as a ventricular rhythm without a recognizable QRS complex, with changing signal morphology from cycle to cycle. Both the incidence and total duration of VT and VF episodes were determined during ischemia and after reperfusion. An arrhythmia score based on the following scale (38) was used to evaluate the severity of arrhythmias: 0 ϭ no arrhythmias; 1 ϭ Ͻ10 s VT or other arrhythmias, no VF; 2 ϭ 11-30 s VT or other arrhythmias, no VF; 3 ϭ 31-90 s VT or other arrhythmias, no VF; 4 ϭ 91-180 s VT or other arrhythmias and/or Ͻ10 s reversible VF; 5 ϭ Ͼ80 s VT or other arrhythmias and/or Ͼ10 s reversible VF; and 6 ϭ irreversible VF. This scale was adapted for a determination of the arrhythmia score per minute after reperfusion, by using a maximum upper VT duration of 60 s. While some VT episodes were thus split between adjacent minutes, this allowed the time course of arrhythmias to be assessed. Data from one rat in the baicalein data set were excluded because of arrhythmias before coronary occlusion. Data with this included rat still showed a significant reduction in arrhythmia score at 3 min after reperfusion with baicalein treatment (P Ͻ 0.02).
Determination of the area at risk. After 30 min reperfusion, the heart was excised and flushed via the aorta with 3 ml of saline. The LAD was reoccluded, and 3 ml of 0.25% Evans blue dye were slowly administered retrogradely via the aorta. Subsequently, the right ventricle and the atria were removed. The nonischemic area was dyed blue, whereas the ischemic area remained unstained. The dye-free area was carefully separated from the stained area and weighed to calculate the area at risk and expressed as a percentage of the weight of the left ventricle (39) .
Statistics. Significance of differences between groups was determined by a pooled t-test where two groups (test and control) were compared, except for the comparison of arrhythmia scores, where the nonparametric Wilcoxon rank sum test was used (Fig. 8A) . To test for the significance of differences and synergism where multiple comparisons were made, a linear mixed effects model fit by maximum likelihood with multiple comparisons was used (SAS software). Data shown are means Ϯ SE. For TMRE experiments, data from single experiments are shown for illustration, because of between-preparation variability (see Fig. 2 ), and average values with significance testing are given for critical data in the text.
RESULTS

AA induces mitochondrial depolarization in cells in suspension.
TMRE is commonly used to measure mitochondrial depolarization in single cells, where polarized mitochondria accumulate TMRE electrophoretically. Such accumulation increases mitochondrial fluorescence in cell images when low levels of TMRE are used (2), although high levels of TMRE can induce fluorescence quenching (37) . We have adapted the TMRE method to give a measure of mitochondrial polarization for cells in suspension. This approach has two important advantages over single-cell experiments: cell suspensions can be divided for concurrent measurement of control and treated cells, and each measurement gives a population-average readout that greatly simplifies data analysis. TMRE uptake by the cells can be measured from TMRE remaining in the supernatant following the centrifugation of an aliquot of cell suspension, because cells with a normal mitochondrial membrane potential deplete TMRE from the medium. This is shown in Fig. 1 , time 0 points, where supernatant TMRE was Ͻ10% of its value when TMRE was fully released by the mitochondrial uncoupler carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP, last point). The cellular uptake of TMRE is a function of both the sarcolemmal and mitochondrial membrane potentials. Figure 1 also shows that most of the dye uptake is associated with the mitochondrial membrane potential rather than with the potential across the sarcolemma and that the effect of AA was to decrease the mitochondrial membrane potential rather than the sarcolemmal membrane potential. KCl (50 mM) added immediately after the removal of the time 0 point essentially depolarizes the sarcolemmal membrane potential without affecting the mitochondrial membrane potential and is associated with a small loss of TMRE ( Fig. 1 ; curve, 50 mM KCl) compared with the control, where 50 mM NaCl was added to the control for osmotic effects ( Fig. 1 ; curve, 50 mM NaCl).
An examination of the 5-min time point in Fig. 1 shows that the effect of KCl was essentially immediate, as would be expected, since its effect on the sarcolemmal membrane potential is immediate. At this time there is little effect of AA on TMRE release, with either NaCl or KCl. Subsequently, however, AA induced substantial TMRE release in either medium. With 50 mM KCl, all of the AA-induced TMRE release after 5 min must be from the mitochondria, since the sarcolemma is already depolarized. Since the AA-induced TMRE release with 50 mM NaCl was of similar magnitude, this suggests that the primary effect of AA in both media was to depolarize the mitochondria but not the sarcolemma.
Is the AA-induced TMRE release via the mitochondrial permeability transition? One criterion commonly applied to test for a role of the mitochondrial permeability transition (MPT) is sensitivity to cyclosporine A (CsA), which binds to mitochondrial cyclophilin D (21) and hence inhibits MPT (12, 17) .
We found that 2 M CsA had no effect on AA-induced TMRE release in myocyte suspensions (Fig. 2) . Lower (0.2 M) and higher (10 M) levels of CsA were also ineffective (not shown). This suggests that AA-induced TMRE release may not be via MPT. Is there a role for LOX in the depolarizing action of AA? We found (not shown) that 50 M oleic acid was not effective at inducing myocyte depolarization under these conditions. Since 12-LOX has been implicated in ischemic preconditioning (9, 18, 42) , a cardioprotective phenomenon thought to be mediated by mitochondrial depolarization via ATP-sensitive K ϩ channels (35), we examined the effect of LOX inhibition on AA-induced TMRE release.
We found that 10 M of LOX inhibitor baicalein strongly inhibited AA-induced TMRE release from myocytes in suspension (Fig. 3) . The effect of baicalein on AA-induced TMRE release was significant: after 15 min, TMRE release in control cells was 49.4 Ϯ 8.1% of the FCCP value, whereas with 10 M baicalein, this was reduced to 14.1 Ϯ 2.8% of the FCCP value (means Ϯ SE, P Ͻ 0.005, n ϭ 5). Since baicalein inhibits both 12-LOX and 15-LOX (13), we also investigated the actions of more specific inhibitors. The 12-LOX inhibitor (10) cinnamyl-3,4-dihydroxy-a-cyanocinnamate (CDC, 1 M) also inhibited (Fig. 3A) , as did the specific inhibitor of 15-LOX, PD-146176 (10 M; Fig. 3B ). This level of PD-146176 does not inhibit rat basophile leukocyte 5-LOX or human platelet 12-LOX at all (49) .
How does AA affect mitochondrial energization? Since mitochondrial polarization requires either electron transport or ATP hydrolysis, we investigated how AA affected this requirement. We found that oligomycin (an inhibitor of oxidative phosphorylation and mitochondrial ATPase) and rotenone (an inhibitor of complex I) themselves individually did not induce much TMRE release, but they each synergistically promoted AA-induced TMRE release from myocytes (Fig. 4) . This suggests that while mitochondrial respiration alone or mitochondrial ATPase alone is sufficient to maintain the mitochondrial membrane potential without AA, in the presence of 50 M AA both mitochondrial ATP hydrolysis and electron transport contribute to its maintenance. We therefore investigated the impact of AA on the metabolic state of the myocytes in more detail.
What role does inhibition of mitochondrial electron transport by AA or its metabolites play in its action to depolarize myocytes? AA is known to uncouple and inhibit the NADlinked respiration of isolated heart mitochondria (11, 36) . In our myocyte suspensions, 50 M AA did stimulate respiration (P Ͻ 0.001, Fig. 5A ). Also, FCCP still increased respiration after AA exposure, so mitochondria were not completely deenergized by this level of AA, at least not at the time of measurement, which lasted for several minutes after the addition of AA. This stimulated rate with AA was therefore consistent with an incomplete uncoupling effect. AA did not much inhibit the rate of respiration with FCCP [to 66.3 Ϯ 4.5 with AA compared with 71.2 Ϯ 8.
This lack of inhibition is surprising, given the powerful inhibition of respiration by AA in isolated mitochondria (11), and indicates that the level of AA at the mitochondria may be much less than the concentration added. AA-induced respiration was also not inhibited by baicalein (Fig. 5B) , suggesting that this effect of AA was not mediated by LOX. There was in fact a small stimulation of respiration, but a similar small stimulation was seen with baicalein alone (Fig. 5B) . AA-induced respiration was, however, blocked by the complex I inhibitor rotenone (not shown), indicating that it does originate from mitochondrial electron transport. Oligomycin, on the other hand, did not block AA-induced respiration (Fig. 5A ). An unexpected observation was that FCCP-induced respiration in myocytes was almost completely blocked by oligomycin (Fig. 5A) , strikingly different from the behavior of isolated mitochondria, and this inhibition could not be overcome by a subsequent addition of pyruvate (Fig. 5A) . If pyruvate was added before FCCP, however, about half of FCCP-induced respiration in the presence of oligomycin did remain (not shown).
What role does inhibition of glycolysis by AA or its metabolites play in its action to depolarize myocytes? A partial uncoupling of mitochondria induces an increase in the rate of ATP utilization of myocytes via the induction of mitochondrial ATPase activity (23) . We therefore investigated the effect of AA on the rate of ATP utilization by the myocytes, and on glycolysis, which can also provide ATP when oxidative phosphorylation is compromised.
The rate of ATP utilization by isolated myocytes can be measured from the rate at which they produce lactate from glycogen without ATP decline, when mitochondrial production 2 M) , or Na pyruvate (5 mM). *P Ͻ 0.005; **P Ͻ 0.001 (n ϭ 4). NS, not significant. B: effect of baicalein on AA-induced O2 consumption; baicalein (10 M) or DMSO were added before AA (50 M) or EtOH. While the effect of AA was again significant (P Ͻ 0.001), the small stimulation by baicalein only reached borderline significance (P ϭ 0.06) without significant interaction (P ϭ 0.2, n ϭ 4).
of ATP is blocked (23, 27) . This condition is achieved with myocytes in a medium without glucose when the complex I inhibitor rotenone is added, and even when the rate of ATP utilization is artificially stimulated with measured levels of uncoupler (23) . We found that for myocytes with rotenone in a glucose-free medium, the initial rate of lactate production could not be sustained unless glucose was added (Fig. 6A) . AA caused a 5.5-fold increase in the initial rate of lactate production with rotenone present, without glucose, which must correspond to a 5.5-fold increase in the rate of ATP utilization induced by AA (Fig. 6A) . This stimulated rate was followed by a complete inhibition of lactate production (Fig. 6A) . We previously concluded that a similar effect of low levels of FCCP results from the complete depletion of a limited glycogen store (23) . The addition of glucose, however, was completely unable to maintain a sustained rate of lactate production under these conditions, suggesting that glycolysis was completely inhibited (Fig. 6A) . In the absence of rotenone, where most of the ATP utilization of the cells is provided by oxidative phosphorylation, the rate of lactate production is very low (Fig.  6B) , although the addition of glucose still increased it (Fig.  6B ). The addition of AA to cells without glucose again stimulated a rapid rate of lactate production, even though no rotenone was present to inhibit oxidative phosphorylation (Fig.  6B) . This suggests that, with AA, oxidative phosphorylation was insufficient to supply the demand for ATP, so that the cells were forced to draw on the limited supply of ATP available from glycogen breakdown. However, even when glucose was present with AA, glycolysis from glucose was unable to maintain the high rate of ATP supply that was achieved by glycogenolysis (Fig. 6B) . The AA-induced rate of ATP utilization was completely blocked by oligomycin (Fig. 6C) , showing that it did originate from mitochondrial ATPase activity. It was not, however, blocked by baicalein (Fig. 6D) .
We checked that the ATP levels were maintained under these conditions. Even in the absence of glucose, over the 3-min time course of the measurement of the rate of lactate generation, the rate of change of ATP was negligible and even slightly (but not significantly) positive: control (no AA), 0.028 Ϯ 2.339 nmol·mg Ϫ1 ·min
Ϫ1
; and 60 M AA, 0.228 Ϯ 0.693 nmol·mg Ϫ1 ·min Ϫ1 (mean slopes Ϯ SD, n ϭ 3). When compared with an AA-induced rate of lactate production of 25 nmol·mg Ϫ1 ·min Ϫ1 (Fig. 6D) , which translates to a rate of ATP utilization of 1.5 ϫ 25 ϭ 37.5 nmol·mg Ϫ1 ·min
, the contribution from changes in ATP levels is negligible. This is in agreement with our earlier studies (23) .
Is there a role for ROS in AA-induced depolarization? AA is known to stimulate ROS production by isolated heart mitochondria (11) . LOX metabolites can also generate ROS in some cell types (7). We therefore tested for a role of ROS by examining the effect of the ROS scavenger mercaptoproprionylglycine on AA-induced depolarization. Mercaptoproprionylglycine blocks ROS formation in cardiac myocytes induced by the mitochondrial ATP-sensitive K ϩ channel opener diazoxide (16) and has been shown to block its protective effect of preconditioning in whole hearts (45) . Figure 7A shows that 1 mM mercaptoproprionylglycine powerfully inhibited the effect of 60 M AA, an effect almost as powerful as the effect of baicalein. This effect of mercaptoproprionylglycine suggests that the LOX effect that induces depolarization may do so via stimulating ROS production or potentiating ROS activity.
How might ROS be inducing mitochondrial depolarization in myocytes?
One possibility is that mitochondrial depolarization is mediated by ROS-induced activation of IMAC, a mechanism for which evidence already exists in myocytes (2) . This channel is inhibited by diisothiocyanatostilbene-disulfonic acid (DIDS) (6) . We therefore tested whether DIDS would inhibit the AA-induced TMRE loss and found that it did significantly inhibit ( Fig. 7B, P Ͻ 0.01 for times 15-60 min,  n ϭ 3) .
Since 4=-chlorodiazepam (Ro5-4864) was reported to inhibit IMAC with an IC 50 of 34 M (5) and this level also inhibited laser flash-induced mitochondrial membrane potential oscillations in isolated guinea pig myocytes (2), we tested the effect of Ro5-4864 on AA-induced mitochondrial depolarization in our rat myocytes. Surprisingly, we found (n ϭ 4) that 34 M Ro5-4864 synergistically increased TMRE release induced by 60 M AA from 8.1 Ϯ 1.8% of FCCP-induced TMRE release above baseline after 30 min to 22.8 Ϯ 6.1% above baseline. The TMRE release induced by AA was significant (P Ͻ 0.02), but the further increase with Ro5-4864 was significantly higher again (P Ͻ 0.02). By contrast, Ro5-4864 alone had no effect (Ϫ0.2 Ϯ 1.3%, P ϭ NS). Similar results were found with 68 M Ro5-4864. Furthermore, PK-11195 (50 M) also potentiated AA-induced TMRE release (not shown).
Since mitochondrial depolarization mediated by IMAC and ROS was previously implicated in arrhythmogenesis following ischemia-reperfusion injury (1, 2), we have also investigated whether LOX activity contributes to such arrhythmogenesis.
Prevention by LOX inhibitor baicalein of arrhythmias induced by ischemia-reperfusion injury. Using an in vivo rat model of ischemia-reperfusion injury, we have found evidence that the LOX inhibitor baicalein has antiarrhythmic activity. Rats were given baicalein (20 mg/kg iv) or solvent control 15 min before coronary occlusion. Baicalein treatment had no significant effect on mean arterial pressure before ischemia (85.6 Ϯ 6.7 with baicalein vs. 80.7 Ϯ 7.8 mmHg with control; means Ϯ SE, P ϭ NS, n ϭ 6) but significantly improved postischemic recovery at 2 min reperfusion (82.4 Ϯ 7.7 with baicalein vs. 43.2 Ϯ 10.6 mmHg with control, mean Ϯ SE, P ϭ Ͻ 0.05, n ϭ 6). Coronary artery ligation resulted in the loss of perfusion to 67.7 Ϯ 1.9% of the left ventricle in the control group and 73.5 Ϯ 3.7% of the left ventricle in the baicalein-treated group (means Ϯ SE, P ϭ NS, n ϭ 6). On reperfusion following 5 min coronary occlusion, VT and/or VF was induced in five of six control rats and three of six baicalein-treated rats (P ϭ NS). However, arrhythmias in the baicalein-treated group were much less severe. The arrhythmia score was reduced to zero in the baicalein-treated group after the first minute of reperfusion, whereas arrhythmias continued for several minutes in the control group (Fig. 8) . The duration of VT in the control group was 88.4 Ϯ 27.4 s, whereas in the baicalein group it was reduced dramatically to 4.0 Ϯ 2.2 s (means Ϯ SE, P Ͻ 0.01, n ϭ 6). No rats died in either group, although one baicalein-treated rat died that was excluded from the data shown because of arrhythmias present before treatment or occlusion (see MATERIALS AND METH-ODS). This is different from the results of Guo et al. (20) with this model, where almost all of the rats died. Our use of isoflurane for anesthesia instead of pentobarbital sodium might account for this difference by enhancing myocardial blood flow (32) or by preconditioning (34) . The effect of baicalein nevertheless does appear to be substantial and suggests that ischemia-reperfusion injury induces arrhythmias via a LOX-mediated mechanism.
DISCUSSION
Recently, evidence has emerged that a direct link may exist between mitochondrial depolarization and potentially arrhyth- mogenic sK ATP activation at the sarcolemma (2). Mitochondrial depolarization induced by local ROS was propagated to neighboring mitochondria and throughout the cell via IMAC activity (2) . Moreover, such IMAC activity does appear to contribute to ischemia-reperfusion-induced arrhythmias in the whole heart (1). The source of ROS that would cause this effect following ischemia-reperfusion injury has, however, been unclear. There is, however, evidence that ROS do contribute to arrhythmias following ischemia-reperfusion injury, as Guo et al. (20) showed that these arrhythmias were inhibited by the ROS scavenger Tempol, using the same model of ischemiareperfusion injury used here. Free fatty acids, which are produced by ischemia-reperfusion injury, are known to increase ROS in isolated heart mitochondria (11). Free fatty acids were long ago proposed to have a role in arrhythmogenesis following ischemia-reperfusion injury, but the hypothesis has not had much support (43) . Our data suggest a mechanism whereby increased free fatty acids and, specifically, AA via LOX may promote arrhythmias following ischemia-reperfusion injury: via induction of mitochondrial depolarization, with characteristics of ROS dependence and DIDS sensitivity very similar to those defined by Aon et al. (2) and Akar et al. (1) .
The level of AA used in this study is not unlike that observed following ischemia-reperfusion injury in rat [63 nmol/g wet wt (15) ], although a direct comparison is difficult because of differences between isolated myocytes and whole hearts. The level of AA at the mitochondria is probably much Ͻ50 M when 50 M AA is added to cell suspensions: respiration of isolated heart mitochondria is strongly inhibited by just a few micromolar of AA (11), whereas the respiration of myocytes is barely inhibited at all by 50 M AA (Fig. 5A ). This suggests that the level of AA seen by the mitochondria is much less than the level added, presumably because of the ability of the myocyte to bind and esterify fatty acids.
The ability of unsaturated fatty acids to depolarize the mitochondria of intact MH1C1 hepatoma cells has been noted previously (47) . Our data suggest that the effect of AA to depolarize mitochondria in myocytes can be separated into two components.
First, there is clearly an immediate metabolic effect of AA to partially uncouple mitochondria (Fig. 5 ) and to induce a mitochondrial ATPase activity (Fig. 6 ). This action may not result in any TMRE release for at least 5 min (see Fig. 7 ), presumably because the mitochondrial ATPase maintains membrane potential. The AA-dependent ATPase activity (20-30 nmol lactate·min Ϫ1 ·mg Ϫ1 , Fig. 6 ) is in good quantitative agreement with the AA-induced increase in respiration (15 nA O 2 ·min Ϫ1 ·mg Ϫ1 , Fig. 5 ), assuming 1.5 nmol ATP/lactate from glycogenolysis and an ATP produced per oxygen atom consumed ratio of 3. This increased rate of ATP utilization by myocytes requires glycogenolysis to supply the need for ATP, even under aerobic conditions in the presence of glucose (Fig.  6B) . Once the glycogen stores are depleted, glycolysis is from glucose alone, and this may be insufficient to maintain the rate of ATP supply needed, since the rate of lactate production declines considerably (Fig. 6B) . Previous studies in our laboratory have shown that glycolysis from glucose can be limited by the failure to recruit glucose transporters to the sarcolemma under conditions of enhanced rates of ATP utilization (23) . It may therefore be that AA and/or its metabolites limit glycolysis by this mechanism. Any inhibition of glycolysis by AA will promote mitochondrial depolarization in addition to the uncoupling effect of AA. Since neither the effect of AA on respiration nor its effect on mitochondrial ATPase is sensitive to baicalein (Figs. 5 and 6 ), this metabolic effect of AA does not appear to involve LOX activity but might be simply an effect of free fatty acids. A similar limited uncoupling effect of free fatty acids has been observed in isolated mitochondria (36) . The metabolic action of AA clearly compromises mito- chondrial energization, as seen by the synergistic effect of rotenone or oligomycin with AA on mitochondrial polarization (Fig. 4) . Oligomycin also promoted AA-induced mitochondrial depolarization in neuronal cultures, suggesting that, there also, mitochondrial ATPase activity was recruited to help maintain the membrane potential (50) .
Second, there is a baicalein-sensitive component of AA action that results in a much greater mitochondrial depolarization than would otherwise occur from its metabolic action alone. When mitochondrial energization is compromised, the impact of the mitochondrial inner membrane channel activity on membrane potential is magnified (35) . If LOX activity were to induce inner membrane channel activity, this might explain the sensitivity of AA-induced mitochondrial membrane potential changes to LOX inhibitors (Fig. 3) . Baicalein does also protect against lipid peroxidation directly, perhaps by binding iron (19) . The action of baicalein cannot therefore be unequivocally attributed to inhibition of LOX, although the similar action of the more specific and potent LOX inhibitors (Fig. 3) does support LOX involvement.
Aon et al. (2) and Akar et al. (1) invoked IMAC activity to explain the DIDS sensitivity of ROS-induced mitochondrial depolarization. However, IMAC is not yet defined at the molecular level. Other well-defined mitochondrial anion channels are also sensitive to DIDS and might be involved. Uncoupling protein (UCP) is a good candidate, because it is known to be stimulated by fatty acids (33) and can also have a highconductance DIDS-sensitive anion channel activity (28) . ROS promote the activity of UCPs, likely mediated by the formation of lipid peroxides that then degrade to aldehydes such as 4-hydroxynonenal (8). Hydroxyl radicals formed from H 2 O 2 in the presence of Fe 2ϩ (Fenton reaction) can initiate lipid peroxidation by the abstraction of hydrogen atoms from unsaturated fatty acyl chains to form conjugated dienes and then peroxyl radicals after a combination with oxygen (22) . The hydroperoxy metabolites of AA and LOX, hydroperoxyeicosatetraenoic acids (HPETEs), are strong promoters of lipid peroxidation because they react with Fe 2ϩ much faster than H 2 O 2 reacts with Fe 2ϩ , to themselves form highly reactive fatty acyl alkoxy and peroxyl radicals. Moreover, superoxide, which normally is dismutated to H 2 O 2 , can fuel this by reducing Fe 3ϩ back to Fe 2ϩ . Hence, HPETEs can amplify lipid peroxidation through a chemical chain reaction, even if they are only present at very low levels (22) . The peroxyl radicals so formed, whether from hydroxyl radicals or from HPETEs, can then decompose into aldehydes such as 4-hydroxynonenal. Thus HPETE-induced modification of UCP to an active anion channel might provide the link between LOX activity and mitochondrial depolarization.
Our observation that IMAC inhibitor Ro5-4864 actually potentiated AA-induced TMRE release in rat myocytes was unexpected, given the observation of Aon et. al. (2) that this level of Ro5-4864 inhibited mitochondrial membrane potential oscillations. These authors did, however, also find that IMAC inhibitors did enhance mitochondrial matrix ROS (presumably by blocking efflux to the cytosol) and PK-11195 did not reduce laser light-induced mitochondrial depolarization in the illuminated zone; it only prevented its propagation out of the zone. AA added to the cell suspension will affect all mitochondria of all cells simultaneously, so the propagation of mitochondrial depolarization is not an issue. Given the known action of AA to stimulate mitochondrial ROS production (11) and the ability of Ro5-4864 and PK-11195 to block mitochondrial superoxide efflux (2), the observed synergism between AA and the IMAC inhibitors on TMRE release may be explained by the promotion of matrix ROS concentrations that subsequently lead to mitochondrial depolarization. A corollary, however, is that the depolarization itself may not be occurring via IMAC, since this channel should be inhibited under these conditions. This supports a role for other DIDS-sensitive anion channels such as UCP as more likely candidates for mediating AA-induced depolarization. Thus there may be significant differences in the mechanism between the mitochondrial depolarization induced by AA and that induced by laser light.
This investigation began as an attempt to determine whether AA might induce mitochondrial depolarization in isolated myocytes by inducing MPT. The MPT is a sudden increase in permeability of the mitochondrial inner membrane resulting from the Ca 2ϩ -induced opening of a hydrophilic channel in the mitochondrial inner membrane, which allows solutes Ͻ1500 mol wt to permeate (25, 29, 30) . MPT has been implicated in ischemia-reperfusion injury in the heart (3). MPT is strongly promoted by free fatty acids in heart mitochondria (31) . In MH1C1 cells, A-23187-induced mitochondrial depolarization was inhibited by CsA and hence was attributed to MPT (46) . Moreover, mitochondrial depolarization was also blocked by phospholipase inhibition and was attributed to AA action (46) , since the direct addition of 0.2 mM AA also induced CsAsensitive mitochondrial depolarization (48) . We found that AA did indeed induce mitochondrial depolarization in myocytes and at much lower levels than those needed to induce mitochondrial depolarization in MH1C1 cells, but by contrast the depolarization in myocytes was not blocked by CsA (Fig. 2) and hence cannot at this point be attributed to MPT. However, this is not conclusive, since MPT-like increases in membrane permeability in isolated heart mitochondria induced by fatty acid were found by others to be CsA insensitive, even though similar effects were CsA sensitive in mitochondria from other organs (14) . MPT can still occur even with cyclophilin D inhibited or absent (4). Our result (Fig. 2) therefore does not exclude a role for MPT in AA-induced TMRE release, but it does not support the hypothesis that MPT is involved.
A limitation of this study is that it was not possible to measure mitochondrial polarization in the rat hearts in vivo, and hence we do not know whether the inhibition of arrhythmias by baicalein was indeed associated with an inhibition of mitochondrial depolarization. Also, since baicalein induced only a reduction in severity of arrhythmias and not in the incidence of arrhythmias and since no fatalities were evident in either experimental group, it is uncertain whether baicalein would decrease the incidence of fatalities in the clinical setting.
In summary, we present evidence for AA-mediated mitochondrial depolarization in isolated myocytes that is mediated by LOX, ROS release, and IMAC activation, as determined by its inhibition by the LOX inhibitor baicalein, the ROS scavenger mercaptoproprionylglycine, and the anion channel inhibitor DIDS. In addition, we found that baicalein suppressed reperfusion arrhythmias in an in vivo rat coronary ligation model where ROS generation was previously shown to contribute to arrhythmogenesis. Given the known links between mitochondrial depolarization and sK ATP activation and that sK ATP activation underlies action potential shortening associated with arrhythmogenesis in ischemic myocardium, our findings suggest a significant role of AA and LOX-mediated ROS generation in arrhythmogenesis following ischemia-reperfusion injury.
